A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation
about
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case seriesAgomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case reportAdjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label studyMelatonin for the treatment of irritable bowel syndromeEfficacy of agomelatine in major depressive disorder: meta-analysis and appraisalIs there a role for agomelatine in the treatment of anxiety disorders?A review of published dataAgomelatine in the treatment of major depressive disorder: an assessment of benefits and risksAgomelatine beyond borders: current evidences of its efficacy in disorders other than major depressionElectroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Melatonin in antinociception: its therapeutic applications.A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV studyNew drugs for bipolar disorder.Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?Role of melatonin in mood disorders and the antidepressant effects of agomelatine.Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review.Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.New insights on the antidepressant discontinuation syndrome.The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.Agomelatine for the treatment of generalized anxiety disorder.Agomelatine-Induced Maculopapular Rash: A Case Report.Comparison between Two Linear Supervised Learning Machines' Methods with Principle Component Based Methods for the Spectrofluorimetric Determination of Agomelatine and Its Degradants.Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.Agomelatine, melatonin and depressive disorder.Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.The combination of agomelatine and ritanserin exerts a synergistic interaction in passive avoidance task.
P2860
Q21203936-A29B5BF3-76B4-450A-9BB8-43F23584D395Q21285010-B6DFAE3C-164C-4B90-ABE2-08EE24F4EC4CQ24619584-563C2037-239A-4CA7-9870-86AD345DE187Q27027366-B19FB071-BEB0-4ECA-84FA-82A93ACF3E94Q28246147-D8B10146-7995-40FE-A96B-31A83986B802Q28292468-DEFE0D32-04C7-44DB-A8FA-10A1BDAE8163Q28651497-8C07D0ED-A069-462D-B348-93619529D7FDQ28651498-48833D06-543D-4DC3-8F9F-2EF48ADC1CECQ33685314-767C7886-D585-49CC-814F-3453E2494705Q35918242-F782F061-B813-4637-94F3-613007390E52Q36040915-E4EA5F03-5AC5-403A-A49A-2D66CDC9868AQ36067329-41EDB6F9-B62C-4FEC-BE00-4665595A47F6Q36466559-230DA3B0-EA01-4BCE-BA31-0C5A6FBA0DDEQ37923845-9728F523-92E1-425D-BA1D-A6BD1140E6C3Q37958033-4A37BA02-9C98-44F3-B565-F59DF97635B6Q38033191-B2B5DFEC-428B-4A25-839E-8FA06965FF2FQ38093228-E4D13C42-277C-444B-AEFC-97C81E1ACDC4Q38203356-A861BEEE-0B52-4C26-9F3E-A8F68058912EQ38238790-5F5A1716-0A19-447C-95CD-92FF2728A076Q38366416-3B8B5A7B-493D-40EB-A1D0-AEEC2D0F661EQ38668480-CA80FDFD-80DB-4854-B09B-3015B82DC2C7Q38865949-1AA7BCE9-CB49-49C4-B000-2185A1C9109DQ38934382-6241E1E0-57A7-452F-9B03-256E139E6756Q39284667-5422FD42-A974-456F-943C-324064C82018Q43131980-36379610-BE81-42B1-BD65-9B4A715E0537Q46936791-D240BC2F-F195-45D6-AA2D-7DF77441EDCAQ47922357-41F47CD7-D247-4033-88EA-3AD332475194Q50623837-78390B99-3D5C-4036-BF69-DCA5B1D37117
P2860
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A systematic, updated review o ...... on its melatonergic modulation
@ast
A systematic, updated review o ...... on its melatonergic modulation
@en
A systematic, updated review o ...... on its melatonergic modulation
@en-gb
A systematic, updated review o ...... on its melatonergic modulation
@nl
type
label
A systematic, updated review o ...... on its melatonergic modulation
@ast
A systematic, updated review o ...... on its melatonergic modulation
@en
A systematic, updated review o ...... on its melatonergic modulation
@en-gb
A systematic, updated review o ...... on its melatonergic modulation
@nl
prefLabel
A systematic, updated review o ...... on its melatonergic modulation
@ast
A systematic, updated review o ...... on its melatonergic modulation
@en
A systematic, updated review o ...... on its melatonergic modulation
@en-gb
A systematic, updated review o ...... on its melatonergic modulation
@nl
P2093
P2860
P1476
A systematic, updated review o ...... on its melatonergic modulation
@en
P2093
Davide Prestia
Giulio Perugi
Salvatore Colicchio
P2860
P304
P356
10.2174/157015910792246227
P407
P577
2010-09-01T00:00:00Z